Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey by Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb, Boris Egloff

“…Objectives To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.Design A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.Setting Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.Participants German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.Primary outcomes (1) The probability to disclose in 2016, predicted by physicians’ experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016.Results Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). …”
Get full text

Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their pharmaceutical significance by Friščić Maja, Vilić Katarina, Jurić Sandra, Pilepić Kroata Hazler, Maleš Željan

“…Extracts obtained from common butterbur (Petasites hybridus), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). …”
Get full text

Solvent‐Based and Matrix‐Matched Calibration Methods on Analysis of Ceftiofur Residues in Milk and Pharmaceutical Samples Using a Novel HPLC Method by Saniye Özcan, Serkan Levent, Nafiz Öncü Can

Subjects: Get full text

Correction: Rehman et al. Fabrication, In Vitro and In Vivo Assessment of Eucalyptol-Loaded Nanoemulgel as a Novel Paradigm for Wound Healing. <i>Pharmaceutics</i> 2022, <i>14,</i> 1971 by Anis Rehman, Muhammad Iqbal, Barkat A. Khan, Muhammad Khalid Khan, Bader Huwaimel, Sameer Alshehri, Ali H. Alamri, Rami M. Alzhrani, Deena M. Bukhary, Awaji Y. Safhi, Khaled M. Hosny

“…Pharmaceutics…”
Get full text

Correction: Fahmy et al. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. <i>Pharmaceutics</i> 2021, <i>13</i>, 20 by Usama A. Fahmy, Omar Fahmy, Nabil A. Alhakamy

“…Pharmaceutics…”
Get full text

Biochemical and antioxidant responses of common carp (Cyprinus carpio) exposed to sublethal concentrations of the antiepileptic and analgesic drug gabapentin by J Blahova, P Mikula, P Marsalek, Z Svobodova

Subjects: Get full text

Commonly available dietary supplements, herbs and medicines – do they pose a risk for liver health? Literature review in the context of the Polish population by Ewa Janczewska, Barbara Janota

Subjects: Get full text

Green nanotechnology: nanoparticle synthesis using Curcuma amada, Curcuma caesia, Curcuma longa, and Curcuma zedoaria by Avinash Gangal, Neeraj K. Sethiya, Manisha Duseja, Ravi K. Shukla, Dheeraj Bisht, Vijay Singh Rana, H. Lalhlenmawia, Shavkatzon Azizov, Deepak Kumar

Subjects: Get full text

SIMULACIÓN DE UNA CADENA SE SUMINISTR O EN EL ÁREA FARMACÉUTICA by Francisco García

Subjects: Get full text

Immunobiologics in juvenile dermatomyositis: a systematic review of promising therapeutic advances by Aline Maria de Oliveira Rocha, Gabriel Fidelis Ribeiro, Juliana Capecce Silva

Subjects: Get full text

Advantages of using biofilms to obtain high-value molecules by microbial biotransformations by Nicoly Subtil de Oliveira, Romeu Cassiano Pucci da Silva Ramos, Rafaela Caldas de Paula, Matheus Gonçalves da Costa Pereira, Rosimeire Takaki Rosa, Luiz Fernando Bianchini, Edvaldo Antonio Ribeiro Rosa

Subjects: Get full text

Travoprost Intracameral Implant in Eyes with Glaucoma or Ocular Hypertension: Early Short-Term Real-World Outcomes by Teymoorian S, Kaur J

Subjects: Get full text

L’Ayurveda by Lucie Dejouhanet

Subjects: Get full text

The impact of the centralized volume-based procurement policy on Chinese pharmaceutical manufacturing firms' R&amp;D investment: A difference-in-differences approach. by Fangjun Qiu, Shouming Chen, Yujia Li, Xianjing Wang, Mengfei Zhu

“…Centralized drug procurement is a common practice worldwide to relieve the healthcare burden and promote high-quality development in the pharmaceutical industry. However, scholars have not yet reached an agreement on whether centralized procurement can facilitate the innovation activities of pharmaceutical firms. …”
Get full text

Determination of Atenolol and Trimetazidine in Pharmaceutical Tablets and Human Urine Using a High Performance Liquid Chromatography-Photo Diode Array Detection Method by Walaa El-Alfy, Omnia A. Ismaiel, Magda Y. El-Mammli, Abdalla Shalaby

“…Linearity was obtained over a concentration range of (1.0-100 μg/mL) for both analytes in standard solutions and the method was successfully applied for determination of target analytes in their pharmaceutical tablets. Excellent linearity was also obtained over concentration ranges of (0.25-25 μg/mL) and (0.5-25 μg/mL) in human urine for TMZ and ATN, respectively. …”
Get full text

Reforming the innovation system to deliver affordable medicines: a conceptual framework of pharmaceutical innovation as a complex adaptive system (forest) and theory of change by Suerie Moon, Adrian Alonso Ruiz, Marcela C. F. Vieira, Kaitlin E. Large, Iulia Slovenski

Subjects: “…Pharmaceutical innovation system…”
Get full text

Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France by Maxime Esvan, Benjamin Bastian, Martin Molina, Adeline Boëffard

“…Objectives To measure medical students’ exposure to pharmaceutical product promotion and incentives nationwide, and to evaluate students’ attitudes towards the pharmaceutical industry, access to education on promotional strategies and knowledge of institutional policies about drug company-student relationships.Design Cross-sectional survey based on a 48-item anonymous questionnaire.Setting All 37 French medical schools, from March to April 2019.Participants French medical students in their 4th year of study and beyond, having studied exclusively in France.Main outcome measure Cumulative frequency of students’ exposure to pharmaceutical product promotion and incentives.Secondary outcome measures Exposure within the last 6 months, attitudes regarding interactions with the industry, access to education on pharmaceutical product promotion and incentives and knowledge of institutional policies.Results 6280 responses were analysed (10.4% out of a total of 60 550 eligible students). 5992 students (96.3% poststratification, 99% CI (96.1% to 96.5%)) had already been exposed to pharmaceutical product promotion and incentives and 4650 (78.1%, 99% CI (77.7% to 78.6%)) within the last 6 months. 5140 students (85.4%, 99% CI (84.8% to 85.8%)) had met a pharmaceutical representative. …”
Get full text

Validation of an RPHPTLC-Densitometric Method Using Silica Gel 60 RP18WF254 for Simultaneous Determination of Nicotinamide in Selected Pharmaceutical Formulations by Małgorzata Dołowy, Alina Pyka

“…Developed method is accurate and precise (CV<3%) and may be successfully applied for the quality control of pharmaceutical formulations containing nicotinamide in the presence of its derivatives, such as N,N-diethylnicotinamide, N-methylnicotinamide, and nicotinic acid.…”
Get full text

Identifying and ranking the circular supply chain implementation challenges using pythagorean fuzzy SWARA approach (case of study: pharmaceutical industry of Guilan province) by Samaneh Rash, Mostafa Ebrahimpour Azbari, Mohammad Rahim Ramazanian

“…We used the proposed method in the pharmaceutical industry of the Guilan province.Findings: In the final results of the research, Strategic Challenges (SCs) and operational and environmental challenges are prioritized.Originality/Value: This research serves as a step for industry practitioners to efficiently and effectively adopt a CSC.…”
Get full text

Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis by Lu Chen, Lu Chen, Pengxiang Zhou, Pengxiang Zhou, Zhengqian Li, Ziyang Wu, Suodi Zhai, Suodi Zhai

“…We included randomized controlled trials (RCTs) comparing intravenous pharmaceutical interventions to prevent EIM with placebo, no intervention, or another pharmaceutical intervention.ResultsForty-eight RCTs involving 4,768 participants randomly assigned to 20 intravenous pharmaceutical interventions and normal saline were included. …”
Get full text